Related Experiment Video

Updated: Jan 28, 2026

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.6K

IPO9 Promotes Ovarian Cancer Progression by Suppressing HMOX1-Dependent Ferroptosis

Yimei Meng1, Peiling Li1, Sujit Nair1

  • 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China, hrbmush.edu.cn.

Human Mutation
|January 26, 2026
PubMed

Insights

Ovarian cancer research identifies MALAT1+ epithelial cells driving immune suppression. The gene IPO9 promotes tumor growth by hindering ferroptosis, suggesting it as a potential therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Ovarian cancer (OC) remains a major threat with suboptimal treatments.
  • Novel therapeutic targets and understanding the immune microenvironment are crucial.

Purpose of the Study:

  • To identify key cell subpopulations and genes in OC using multiomics data.
  • To investigate the role of MALAT1+ epithelial cells and IPO9 in OC progression and immune suppression.

Main Methods:

  • Integrated multiomics data (TCGA, GEO, IEU-Open-GWAS).
  • Utilized scRNA-seq, scPagwas, BayesPrism, WGCNA, EdU, colony formation, Transwell assays, and ferroptosis markers.
  • Analyzed MALAT1+ epithelial cells and IPO9 gene expression and function.

Main Results:

  • MALAT1+ epithelial cells were identified as a core subpopulation in OC, linked to poorer survival and suppressed immunity.
  • Higher infiltration of these cells correlated with OC immune dynamics and mutations.
  • IPO9 was found to be upregulated in OC, promoting progression by inhibiting HMOX1-dependent ferroptosis.

Conclusions:

  • MALAT1+ epithelial cells are key drivers of immune suppression in ovarian cancer.
  • IPO9 presents a promising therapeutic target for improving immunotherapy efficacy in OC.
  • This study offers new strategies for ovarian cancer treatment development.
Keywords:
HMOX-1IPO9ferroptosisimmune microenvironmentovarian cancer

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.8K
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

14.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Frequency-dependent Selection01:21

Frequency-dependent Selection

When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
23.6K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.7K
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.7K